Literature DB >> 21631525

SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation.

M Fernández-Cancio1, L Audí, P Andaluz, N Torán, C Piró, M Albisu, M Gussinyé, D Yeste, M Clemente, J Martínez-Mora, A Blanco, M L Granada, M Marco, J Ferragut, J P López-Siguero, M Beneyto, C Carles, A Carrascosa.   

Abstract

One hundred and forty-six index patients with 46,XY DSD in whom gonads were confirmed as testes were consecutively studied for a molecular diagnosis during the period 2002-2010. AR gene was analysed in all patients as the first candidate gene, yielding a mutation in 42.5% of cases and SRD5A2 gene was analysed as the second candidate gene, resulting in the characterization of 10 different mutations (p.Y91D, p.G115D, p.Q126R, p.R171S, p.Y188CfsX9, p.N193S, p.A207D, p.F219SfsX60, p.R227Q and p.R246W) in nine index patients (6.2% of the total number of 46,XY DSD patients). One of the mutations (p.Y188CfsX9) has never been reported. In addition, we genotyped SRD5A2 gene p.V89L and c.281+15T>C polymorphisms in 46,XY DSD and in 156 normal adult males and found that patients with SRD5A2 mutations or without a known molecular diagnosis presented a higher frequency of homozygous p.L89, homozygous TT and combined CCTT genotypes compared with controls. This result suggests that 46,XY DSD patient phenotypes may be influenced by SRD5A2 polymorphism genotypes. SRD5A2 gene mutations may not be as infrequent as previously considered in 46,XY DSD patients with variable degrees of external genitalia virilization at birth and normal T production and appears to be the second aetiology in our series.
© 2011 The Authors. International Journal of Andrology © 2011 European Academy of Andrology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631525     DOI: 10.1111/j.1365-2605.2010.01136.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  9 in total

1.  Molecular diagnosis of 5α-reductase type II deficiency in Brazilian siblings with 46,XY disorder of sex development.

Authors:  Flávia Leme Leme de Calais; Fernanda Caroline Soardi; Reginaldo José Petroli; Ana Letícia Gori Lusa; Roberto Benedito de Paiva E Silva; Andréa Trevas Maciel-Guerra; Gil Guerra-Júnior; Maricilda Palandi de Mello
Journal:  Int J Mol Sci       Date:  2011-12-19       Impact factor: 5.923

2.  Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency.

Authors:  Tong Cheng; Hao Wang; Bing Han; Hui Zhu; Hai-Jun Yao; Shuang-Xia Zhao; Wen-Jiao Zhu; Hua-Ling Zhai; Fu-Guo Chen; Huai-Dong Song; Kai-Xiang Cheng; Yang Liu; Jie Qiao
Journal:  Asian J Androl       Date:  2019 Nov-Dec       Impact factor: 3.285

3.  Differences of adrenal-derived androgens in 5α-reductase deficiency versus androgen insensitivity syndrome.

Authors:  Bing Han; Hui Zhu; Haijun Yao; Jianwei Ren; Patrick O'Day; Hao Wang; Wenjiao Zhu; Tong Cheng; Richard J Auchus; Jie Qiao
Journal:  Clin Transl Sci       Date:  2021-11-11       Impact factor: 4.689

4.  Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD

Authors:  Neşe Akcan; Oya Uyguner; Firdevs Baş; Umut Altunoğlu; Güven Toksoy; Birsen Karaman; Şahin Avcı; Zehra Yavaş Abalı; Şükran Poyrazoğlu; Agharza Aghayev; Volkan Karaman; Rüveyde Bundak; Seher Başaran; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2022-02-09

5.  Accuracy of Urinary Etiocholanolone/Androsterone Ratio as Alternative to Serum Testosterone/Dihydrotestosterone Ratio for Diagnosis of 5 Alpha-reductase Type 2 Deficiency Patients and Carriers in Indonesia.

Authors:  Nanis Sacharina Marzuki; Firman Pratama Idris; Hannie Kartapradja; Shirley Renata; Alida Harahap; Jose Rizal Latief Batubara
Journal:  Int J Endocrinol Metab       Date:  2021-04-18

6.  46,XY disorder of sexual development resulting from a novel monoallelic mutation (p.Ser31Phe) in the steroid 5α-reductase type-2 (SRD5A2) gene.

Authors:  Bertha Chávez; Luis Ramos; Rita Gómez; Felipe Vilchis
Journal:  Mol Genet Genomic Med       Date:  2014-03-16       Impact factor: 2.183

7.  Human MAMLD1 Gene Variations Seem Not Sufficient to Explain a 46,XY DSD Phenotype.

Authors:  Núria Camats; Mónica Fernández-Cancio; Laura Audí; Primus E Mullis; Francisca Moreno; Isabel González Casado; Juan Pedro López-Siguero; Raquel Corripio; José Antonio Bermúdez de la Vega; José Antonio Blanco; Christa E Flück
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

8.  Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency.

Authors:  Mónica Fernández-Cancio; Núria Camats; Christa E Flück; Adam Zalewski; Bernhard Dick; Brigitte M Frey; Raquel Monné; Núria Torán; Laura Audí; Amit V Pandey
Journal:  Pharmaceuticals (Basel)       Date:  2018-04-29

9.  Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency.

Authors:  Nanis S Marzuki; Firman P Idris; Hannie D Kartapradja; Alida R Harahap; Jose R L Batubara
Journal:  Int J Endocrinol       Date:  2019-12-01       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.